CSGs, Internal

CSG's Internal Battle Over Tatra Trucks Complicates US Expansion Story as Stock Skids

25.06.2026 - 03:43:08 | boerse-global.de

Czechoslovak Group's shares plunge 32% as minority partner contests loan from owner's firm, while company hires ex-Northrop executive for US growth.

CSG Faces Governance Battle Over Tatra Trucks Loan Amid US Expansion Push
CSGs - CSG's Internal Battle Over Tatra Trucks Complicates US Expansion Story as Stock Skids 25.06.2026 - Bild: über boerse-global.de

The Czechoslovak Group finds itself fighting on two fronts—pushing ahead with a major American manufacturing push while fending off a governance challenge from a minority partner in its Czech truck unit. The tension is spilling into the stock, which has now surrendered nearly a third of its value in the past month alone.

Shares closed Wednesday at €12.93 in Amsterdam, just a whisker above the 52-week trough of €12.65 hit the previous day. The decline accelerated after news emerged of a disputed loan arrangement at Tatra Trucks, the heavy-duty vehicle maker where CSG holds a 65% stake. Promet Tools, which owns the remaining 35%, has objected to a loan of 2.2 billion Czech crowns from Ytara SPV, a company controlled by CSG owner Michal Strnad.

Promet had earlier blocked a planned capital increase that required 80% shareholder approval. CSG then pushed through the loan instead, which needed only a simple majority. The minority investor argues the move turns Strnad into Tatra's sole significant creditor and could pave the way for a full takeover of the truck manufacturer under certain conditions. Promet has formally protested the shareholder meeting resolution and promised further legal action to halt the transaction.

CSG insists the loan is needed for investment—expanding production capacity and modernising Tatra's manufacturing lines. It also points out that Ytara SPV is not part of the CSG group, and that CSG itself, as an Amsterdam-listed entity, could not directly extend the loan. Governance watchers are now circling, given the obvious related-party nature of the deal and the concentration of control it creates.

Should investors sell immediately? Or is it worth buying CSG?

The corporate governance spat comes at a particularly vulnerable moment for CSG's share price, which has dropped roughly 32% in 30 days and sits nearly 65% below its January all-time high. That makes the positive operational news from the US even harder for management to explain away.

On the same Wednesday the stock fell 7% to €12.80 during intraday trading, the company announced a high-profile Washington hire. David Jacobs, a 15-year veteran of Northrop Grumman and Raytheon, will run CSG Defense North America from a new office in the US capital. His brief: steer the long-term North America strategy and scout acquisition targets. During his time at Northrop, Jacobs led M&A strategy, and before that he advised on more than 60 transactions worth over $200 billion at Merrill Lynch.

The personnel move dovetails with CSG's major US contract win. Its subsidiary MSM Group North America recently secured a $635 million deal to build a new artillery factory in Iowa, with construction slated to kick off this summer. The order backlog across the group now stands at €17 billion, and first-quarter revenue rose by double digits to €1.54 billion, with operating profit hitting €372 million. Management has reaffirmed full-year guidance of around €7.5 billion in sales.

CSG at a turning point? This analysis reveals what investors need to know now.

Yet the market is shrugging off all of that. The stock continues to test its 52-week floor, and the governance dispute at Tatra adds a layer of uncertainty that an otherwise impressive operational story cannot mask. The next flashpoint will be whether Promet's legal challenge can actually stop the loan from being disbursed—and whether CSG can push ahead with Tatra's modernisation without further delay. If not, the pressure on the shares is unlikely to lift soon.

Ad

CSG Stock: New Analysis - 25 June

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSGS | boerse | 69621022 |